down arrow

Pluri, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US72942G1040
  • NASDAQ: PSTI
USD
1.03
0.06 (6.17%)

Oct 01

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Coeptis Therapeutics Holdings, Inc.
Pluri, Inc.
OncoCyte Corp.
Equillium, Inc.
Enlivex Therapeutics Ltd.
Seelos Therapeutics, Inc.
Cyclo Therapeutics, Inc.
Pieris Pharmaceuticals, Inc.
Elevation Oncology, Inc.
Unity Biotechnology, Inc.
Rain Oncology, Inc.

Why is Pluri, Inc. ?

1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -33.32
2
The company has declared Negative results for the last 3 consecutive quarters
  • NET SALES(HY) At USD 0.5 MM has Grown at -39.15%
  • OPERATING CASH FLOW(Y) Lowest at USD -19.58 MM
  • RAW MATERIAL COST(Y) Grown by 11.38% (YoY)
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -78.34%, its profits have fallen by -36.7%
4
Below par performance in long term as well as near term
  • Along with generating -78.34% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Pluri, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Pluri, Inc.
-77.01%
-1.10
75.02%
S&P 500
14.23%
1.09
13.22%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
18.53%
EBIT Growth (5y)
6.04%
EBIT to Interest (avg)
-33.32
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
1.04%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-2.23
EV to EBIT
-1.94
EV to EBITDA
-1.98
EV to Capital Employed
40.98
EV to Sales
36.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2108.22%
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET PROFIT(HY)

Higher at USD -11.35 MM

OPERATING PROFIT(Q)

Highest at USD -5.42 MM

PRE-TAX PROFIT(Q)

Highest at USD -6.11 MM

EPS(Q)

Highest at USD -0.54

-13What is not working for the Company
NET SALES(HY)

At USD 0.5 MM has Grown at -39.15%

OPERATING CASH FLOW(Y)

Lowest at USD -19.58 MM

RAW MATERIAL COST(Y)

Grown by 11.38% (YoY

CASH AND EQV(HY)

Lowest at USD 17.38 MM

Here's what is working for Pluri, Inc.

Net Profit
Higher at USD -11.35 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Profit
Highest at USD -5.42 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD -6.11 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

EPS
Highest at USD -0.54
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for Pluri, Inc.

Net Sales
At USD 0.5 MM has Grown at -39.15%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Operating Cash Flow
Lowest at USD -19.58 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Cash and Eqv
Lowest at USD 17.38 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 11.38% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading